These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11503139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Haemorheological changes in patients with systemic lupus erythematosus do not seem to be related to thrombotic events.
    Vayá A, Murado J, Santaolaria M, Simó M, Micó L, Calvo J, Todolí J, Ricart JM.
    Clin Hemorheol Microcirc; 2008; 38(1):23-9. PubMed ID: 18094455
    [Abstract] [Full Text] [Related]

  • 6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 7. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 8. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A, Cheung BM, Mok CC, Leung R, Lau CS.
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A.
    Arthritis Rheum; 2006 Dec 15; 55(6):892-9. PubMed ID: 17139666
    [Abstract] [Full Text] [Related]

  • 12. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH.
    Scand J Rheumatol; 2009 Dec 15; 38(2):121-7. PubMed ID: 18991189
    [Abstract] [Full Text] [Related]

  • 13. Abnormal plasma and serum viscosity in systemic lupus erythematosus (SLE): a Jamaican study.
    Reid HL, De Ceulaer K.
    Clin Hemorheol Microcirc; 1999 Dec 15; 20(3):175-80. PubMed ID: 10463841
    [Abstract] [Full Text] [Related]

  • 14. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S, Pereira DA, Costallat LT.
    Lupus; 2008 Nov 15; 17(11):1023-8. PubMed ID: 18852227
    [Abstract] [Full Text] [Related]

  • 15. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST.
    Arthritis Rheum; 2004 Mar 15; 50(3):858-65. PubMed ID: 15022328
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Mar 15; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 17. The rate and pattern of organ damage in late onset systemic lupus erythematosus.
    Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G, Systemic Lupus International Collaborating Clinics.
    J Rheumatol; 2002 May 15; 29(5):913-7. PubMed ID: 12022349
    [Abstract] [Full Text] [Related]

  • 18. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ.
    Intern Med J; 2006 Apr 15; 36(4):237-43. PubMed ID: 16640741
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.
    Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C.
    Rheumatology (Oxford); 2003 Jun 15; 42(6):758-62. PubMed ID: 12730535
    [Abstract] [Full Text] [Related]

  • 20. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, Ferraccioli GF.
    Arthritis Rheum; 2007 Dec 15; 57(8):1461-72. PubMed ID: 18050188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.